Detalhe da pesquisa
1.
Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort.
J Hepatol
; 78(3): 501-512, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36423805
2.
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.
BMC Infect Dis
; 22(1): 94, 2022 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086481
3.
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta.
J Hepatol
; 73(5): 1046-1062, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32634548
4.
Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis.
J Hepatol
; 73(6): 1379-1390, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32649971
5.
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
Lancet
; 393(10179): 1453-1464, 2019 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30765123
6.
Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for 8 weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosis.
Liver Int
; 40(8): 1853-1859, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32383275
7.
Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study.
Br J Cancer
; 118(3): 325-330, 2018 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29169182
8.
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients.
J Hepatol
; 66(1): 39-47, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27622858
9.
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.
Gastroenterology
; 147(1): 132-142.e4, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24704719
10.
Risk factors for hepatocellular carcinoma in Caucasian patients with non-viral cirrhosis: the importance of prior obesity.
Liver Int
; 35(7): 1872-6, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25522809
11.
Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial.
J Hepatol
; 60(5): 962-8, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24480619
12.
TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial.
JHEP Rep
; 5(4): 100689, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36937990
13.
Non-invasive diagnosis and follow-up of autoimmune hepatitis.
Clin Res Hepatol Gastroenterol
; 46(1): 101772, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34332126
14.
Non-invasive diagnosis and follow-up of primary sclerosing cholangitis.
Clin Res Hepatol Gastroenterol
; 46(1): 101775, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34332142
15.
Infected pancreatic necrosis complicating severe acute pancreatitis in critically ill patients: predicting catheter drainage failure and need for necrosectomy.
Ann Intensive Care
; 12(1): 71, 2022 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35916981
16.
Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response.
Clin Res Hepatol Gastroenterol
; 46(6): 101923, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405354
17.
Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study.
Lancet Gastroenterol Hepatol
; 7(5): 416-425, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35202597
18.
Takayasu arteritis associated with hepatic sinusoidal dilatation.
Ann Hepatol
; 10(4): 559-61, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21911899
19.
Predictive Factors of Chemotherapy Initiation after Biliary Drainage for Advanced Biliary Tract Cancer: A Retrospective Multicenter Study.
J Gastrointestin Liver Dis
; 30(2): 254-258, 2021 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951116
20.
Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort.
Clin Res Hepatol Gastroenterol
; 45(1): 101459, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32595103